Characteristics Associated with Ventricular Tachyarrhythmias and Their Prognostic Impact in Heart Failure with Mildly Reduced Ejection Fraction

被引:0
|
作者
Schmitt, Alexander [1 ]
Behnes, Michael [1 ]
Rusnak, Jonas [2 ]
Akin, Muharrem [3 ]
Reinhardt, Marielen [1 ]
Abel, Noah [1 ]
Forner, Jan [1 ]
Mueller, Julian [4 ]
Weidner, Kathrin [1 ]
Abumayyaleh, Mohammad [1 ]
Akin, Ibrahim [1 ]
Schupp, Tobias [1 ]
机构
[1] Heidelberg Univ, Univ Med Ctr Mannheim, Med Fac Mannheim, Dept Med 1,Sect Invas Cardiol, D-68167 Mannheim, Germany
[2] Univ Hosp Heidelberg, Dept Cardiol Angiol & Pneumol, D-69047 Heidelberg, Germany
[3] Ruhr Univ Bochum, St Josef Hosp, Dept Cardiol, D-44791 Bochum, Germany
[4] Univ Freiburg, Univ Heart Ctr Freiburg Bad Krozingen, Fac Med, Dept Cardiol, D-79106 Freiburg, Germany
关键词
heart failure with mildly reduced ejection fraction; HFmrEF; ventricular tachyarrhythmias; ventricular tachycardia; sudden cardiac death; SUDDEN CARDIAC DEATH; ACUTE MYOCARDIAL-INFARCTION; EUROPEAN ASSOCIATION; IMPROVED SURVIVAL; WALL STRESS; DEFIBRILLATOR; TACHYCARDIA; ARRHYTHMIAS; OUTCOMES; PREVENTION;
D O I
10.3390/jcm13092665
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The occurrence of ventricular tachyarrhythmias represents an established risk factor of mortality in heart failure (HF). However, data concerning their prognostic impact in heart failure with mildly reduced ejection fraction (HFmrEF) is limited. Therefore, the present study aims to investigate patient characteristics associated with ventricular tachyarrhythmias and their prognostic impact in patients with HFmrEF. Methods: Consecutive patients hospitalized with HFmrEF (i.e., left ventricular ejection fraction 41-49% and signs and/or symptoms of HF) were retrospectively included at one institution from 2016 to 2022. The prognosis of patients with HFmrEF and different types of ventricular tachyarrhythmias (i.e., non-sustained ventricular tachycardia (nsVT), sustained VT (sVT), and ventricular fibrillation (VF) was investigated for the primary endpoint of long-term all-cause mortality at 30 months. Secondary endpoints included in-hospital all-cause mortality and long-term HF-related rehospitalization at 30 months. Results: From a total of 2184 patients with HFmrEF, 4.4% experienced ventricular tachyarrhythmias (i.e., 2.0% nsVT, 0.7% sVT, and 1.6% VF). The occurrence of nsVT was associated with higher New York Heart Association (NYHA) functional class, whereas the incidence of sVT/VF was associated with acute myocardial infarction and ischemic heart disease. However, nsVT (25.0%; HR = 0.760; 95% CI 0.419-1.380; p = 0.367) and sVT/VF (28.8%; HR = 0.928; 95% CI 0.556-1.549; p = 0.776) were not associated with a higher risk of long-term all-cause mortality compared to patients with HFmrEF without ventricular tachyarrhythmias (31.5%). In-hospital cardiovascular mortality was more frequently observed in patients with HFmrEF and sVT/VF compared to those with HFmrEF but without sustained ventricular tachyarrhythmias (7.7% vs. 1.5%; p = 0.004). Finally, the risk of rehospitalization for worsening HF was not affected by the presence of ventricular tachyarrhythmias. Conclusions: The occurrence of ventricular tachyarrhythmias in patients hospitalized with HFmrEF was low and not associated with long-term prognosis.
引用
收藏
页数:23
相关论文
共 50 条
  • [31] Prognostic Impact of Comorbidities on Mortality in Patients with Heart failure and Preserved Ejection Fraction vs Heart Failure with Reduced Ejection Fraction
    Ather, Sameer
    Chan, Wenyaw
    Bozkurt, Biykem
    Aguilar, David
    Ramasubbu, Kumudha
    Deswal, Anita
    CIRCULATION, 2010, 122 (21)
  • [32] Total 25-Hydroxyvitamin D Is an Independent Marker of Left Ventricular Ejection Fraction in Heart Failure with Reduced and Mildly Reduced Ejection Fraction
    Szabo, Timea Magdolna
    Nagy, Elod Erno
    Kirchmaier, Adam
    Heidenhoffer, Erhard
    Gabor-Kelemen, Hunor-Laszlo
    Frasineanu, Marius
    Cseke, Judit
    German-Sallo, Marta
    Frigy, Attila
    BIOMOLECULES, 2023, 13 (11)
  • [33] Heart failure with mildly reduced ejection fraction: retrospective study of ejection fraction trajectory risk
    Miller, Robert J. H.
    Nabipoor, Majid
    Youngson, Erik
    Kotrri, Gynter
    Fine, Nowell M.
    Howlett, Jonathan G.
    Paterson, Ian D.
    Ezekowitz, Justin
    McAlister, Finlay A.
    ESC HEART FAILURE, 2022, 9 (03): : 1564 - 1573
  • [34] Effect of heart failure pharmacotherapies in patients with heart failure with mildly reduced ejection fraction
    Schupp, Tobias
    Bertsch, Thomas
    Reinhardt, Marielen
    Abel, Noah
    Schmitt, Alexander
    Lau, Felix
    Abumayyaleh, Mohammad
    Akin, Muharrem
    Weiss, Christel
    Weidner, Kathrin
    Behnes, Michael
    Akin, Ibrahim
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2024, 31 (11) : 1347 - 1360
  • [35] Heart failure pharmacological treatments and outcomes in heart failure with mildly reduced ejection fraction
    Stolfo, Davide
    Lund, Lars H.
    Sinagra, Gianfranco
    Lindberg, Felix
    Dahlstrom, Ulf
    Rosano, Giuseppe
    Savarese, Gianluigi
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2023, 9 (06) : 526 - 535
  • [36] Epidemiology and clinical characteristics of hospitalized patients with heart failure with reduced, mildly reduced, and preserved ejection fraction
    Rywik, Tomasz M.
    Dorynska, Agnieszka
    Wisniewska, Anna
    Ceglowska, Urszula
    Drohomirecka, Anna
    Topor-Madry, Roman
    Lazarczyk, Hubert
    Polaska, Paula
    Leszek, Przemyslaw
    Zielinski, Tomasz
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2022, 132 (05):
  • [37] Heart failure with preserved, mildly reduced, and reduced left ventricular ejection fraction in patients with transthyretin amyloid cardiomyopathy
    Jadan Luzuriaga, Georgina Del Cisne
    Kerges Bueno, Bruno Vaz
    Pereira, Natalia Melo
    Espinoza Romero, Cristhian Vicente
    Peixoto da Fonseca, Guilherme Wesley
    Ianni, Barbara Maria
    Alvarez Ramires, Felix Jose
    Mady, Charles
    Fernandes, Fabio
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2024, 31 : S50 - S51
  • [38] Heart failure with reduced, mildly reduced, or preserved left ventricular ejection fraction: Has reasoning been lost?
    Xanthopoulos, Andrew
    Giamouzis, Grigorios
    Skoularigis, John
    Triposkiadis, Filippos
    WORLD JOURNAL OF CARDIOLOGY, 2022, 14 (07): : 438 - 445
  • [39] Heart failure with mid-range or mildly reduced ejection fraction
    Savarese, Gianluigi
    Stolfo, Davide
    Sinagra, Gianfranco
    Lund, Lars H.
    NATURE REVIEWS CARDIOLOGY, 2022, 19 (02) : 100 - 116
  • [40] Breakthroughs in the treatment of heart failure with mildly reduced and preserved ejection fraction
    Talha, Khawaja M.
    Butler, Javed
    CLINICAL CARDIOLOGY, 2022, 45 : S31 - S39